{
    "organizations": [],
    "uuid": "f4502f134b503f0e1e178bb01ca8701ffe5a2d27",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-china-regenerative-medicine-intern/brief-china-regenerative-medicine-international-posts-fy-loss-attributable-to-owners-of-co-of-hk158-5-mln-idUSFWN1R90TV",
    "ord_in_thread": 0,
    "title": "BRIEF-China Regenerative Medicine International Posts FY Loss Attributable To Owners Of Co Of HK$158.5 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 28 (Reuters) - China Regenerative Medicine International Ltd:\n* FY REVENUE HK$503.7, UP 41.1% * FY LOSS ATTRIBUTABLE TO OWNERS OF CO HK$158.5 MILLION VERSUS LOSS OF HK$184.5 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-28T07:04:00.000+03:00",
    "crawled": "2018-03-28T18:50:58.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "china",
        "regenerative",
        "medicine",
        "international",
        "ltd",
        "fy",
        "revenue",
        "hk",
        "fy",
        "loss",
        "attributable",
        "owner",
        "co",
        "hk",
        "million",
        "versus",
        "loss",
        "hk",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}